Archive for June, 2010
New Clinical Study Shows Patients With Type 2 Diabetes May Be Able To Tolerate Higher Doses Of Metformin Using GLUMETZA
Wednesday, June 30th, 2010Depomed, Inc. (NASDAQ:DEPO) and Santarus, Inc. (NASDAQ:SNTS) announced new data suggesting that patients previously intolerant of metformin may be able to tolerate higher doses of metformin when treated with GLUMETZA® (metformin HCl extended release tablets). The findings [abstract #0729-P] will be presented at the 70th Scientific Sessions of the American Diabetes Association (ADA) in Orlando [...]
Jack3d, Tropical Fruit Position
Wednesday, June 30th, 2010Targeting flight-or-fight hormone response to combat heart failure
Wednesday, June 30th, 2010Scientists found that two experimental drugs have the potential to restore pumping strength to failing hearts by ensuring adrenalin’s ability to drive heartbeat strength is maintained, and not thwarted, as it typically is in heart failure patients. When tested in human-like mouse models of heart failure, the therapies were found to slow, and in some [...]
